2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Rating of “Moderate Buy” from Analysts
2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, four have given a buy rating and one […]
More Stories
US Property Taxes Grow 3 Percent on Average in 2025, Outpacing Inflation
By Rob Sabo Property taxes are rising across the United States and, on average, have outpaced inflation. Homeowners in 2025...
Shane Lowry Makes Golf History With His 2nd Masters Hole-in-One
By Ross Kelly There are millions of casual golfers around the world who dream some day of recording an ace...
Treasury, IRS Propose Rules for 1 Percent Remittance Tax on Some Money Sent to Foreign Countries
By Naveen Athrappully The Internal Revenue Service and the Department of the Treasury proposed regulations on Friday regarding the new...
Hezbollah Leader Says Group Would Continue to Fight Israel After Strikes
By Jack Phillips The leader of Lebanese terrorist organization Hezbollah has said that his group would continue to fight Israel,...
IBM to Pay $17 Million to Settle Allegations of Discrimination
By Jacki Thrapp IBM will pay millions of dollars to resolve allegations that it failed to comply with anti-discrimination requirements...
Trump Says US ‘Loading up the Ships’ Ahead of Iran Talks, Signals Military Option If Diplomacy Fails
By Tom Ozimek President Donald Trump said the United States is preparing military options if negotiations with Iran fail to...